Orientation arbitration

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Z124 patent solves the following problem:

A substantial number of handheld devices Computing, such as cellular phones, tablets, and E-Readers, make use of a touch screen display will not only save the display information to the user, but also to take inputs from the user's command interface. While touch screen display can increase the configurability of the handheld device and to provide a wide variety of user interface options, this flexibility often comes at a price. The two use the touch screen to provide for and receive user commands, while flexible for the user, in order to obfuscate the display, and cause visual clutter, thus leading to user frustration and loss of yield.

Our analysis of this patent is as follows:

Z124’s patent US 8996073 B2 deals with Orientation arbitration.
Methods and devices for Configuring and displaying individual screens display a multi-display device. Particularly, the method includes determining and presenting the display orientation on each display independent of other performances. The creative approach and become a picture display orientation on a display screen while simultaneously presenting a landscape display orientation on another display screen. Show the orientation will be based on the desire of the user and / or requirements for a host application. The rotation of the multi-display device, each screen display can be configured to maintain its orientation or can be configured to allow the display orientation to change, for example from the picture to the scene orientation. The display orientation characteristics for each display screen can be user selectable.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Compounds

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Glaxo Group Limited patent solves the following problem:

Syk is a non-receptor tyrosine kinase involved in coupling activated immunoreceptors signal consuming events that mediate diverse cellular responses, including proliferation, distinction, and phagocytosis. Syk is widely expressed in hematopoietic cells. Syk inhibitor with potential anti-inflammatory and immunomodulating activities. They inhibit SYK-mediated IgG Fc epsilon and gamma receptor and BCR receptor signaling, resulting in inhibition of activation of mast cells, macrophages, and B-cells and relevant inflammatory responses and tissue damage. Mast cells play a major role in type I hypersensitivity reactions associated with urticaria, bronchial asthma, anaphylaxis and other allergic conditions. Therefore, SYK inhibitor has attracted interest from a number of therapeutic areas, including the treatment of rheumatoid arthritis, B-cell lymphoma, asthma, rhinitis and cutaneous disorders such as acute and chronic urticaria, mastocytosis, cutaneous lupus , atopic dermatitis, autoimmune bullous conditions including Pemphigus and pemphigoid and other mast cell mediated skin disease.

Our analysis of this patent is as follows:

Glaxo Group Limited’s patent US 8993560 B2 deals with Compounds.
A compound of formula (I): or a salt thereof; which is an inhibitor of spleen tyrosine kinase (SYK) and therefore potential use in the treatment of diseases resulting from inappropriate activation of mast cells, macrophages, and B-cells and related inflammatory responses and tissue damage, for example inflammatory diseases and / or allergic conditions, in cancer therapy, especially heme malignancies, and autoimmune conditions.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Low protein infant formula with increased essential amino acids

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The N.V. Nutricia patent solves the following problem:

Knowledge of the basic amino acid in (preterm) infants is important because excessive or insufficient drinking may lead to long-term illnesses such as obesity (Singhal et al (2002) Am J Clin Nutr 75: . 993-9) or suboptimal growth and impaired neurodevelopment outcome (Stephens et al (2009) Pediatrics 2009; 123: 1337-43).

Our analysis of this patent is as follows:

N.V. Nutricia’s patent US 8987196 B2 deals with Low protein infant formula with increased essential amino acids.
The present invention of an improved balance of essential branched chain amino acid leucine, isoleucine and valine in baby formula.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Merck Sharp & Dohme Corp. patent solves the following problem:

Spleen Tyrosine Kinase (SYK) is a protein tyrosine kinase described as a key mediator of immunoreceptor signaling a host of inflammatory cells including mast cells, B-cells, macrophages and neutrophils. These immunoreceptors, including Fc receptor and the B-cell receptor, is important for allergic diseases, and antibody-mediated autoimmune diseases and thus pharmacologically interfering SYK conceivably treat these diseases.

Our analysis of this patent is as follows:

Merck Sharp & Dohme Corp.’s patent US 8987456 B2 deals with 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors.
invention provides certain 3-pyridyl formamide-containing compounds of Formula (I) (I) or pharmaceutically acceptable salts thereof, wherein A and B as described here. invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated spleen tyrosine kinase (SYK) kinase.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Vehicle fuel economy system

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The StormBlok Systems, Inc. patent solves the following problem:

Now most tractor-trailers and about 6-7 mpg fuel leaving significant potential for improving fuel economy of tractor-trailers. Reduced fuel consumption of tractor-trailers that directly impact cost of transportation of goods, serving businesses and consumers alike.

Our analysis of this patent is as follows:

StormBlok Systems, Inc.’s patent US 8985677 B2 deals with Vehicle fuel economy system.
A fairing assembly for a trailer with a wheel set and a hook, the fairing assembly consisting of a fairing connected to an underside of the trailer intermediate hooks, and the wheels set, the fairing including (i) a pair of opposing lateral surfaces separated by a distance, (ii) a lower surface spaced from the underside of the trailer, and (ii) a first face, the first face substantially spanning the distance, where the first face includes an intake opening, wherein at least one of the lower face or the lateral surfaces include an exit opening, and a flow path fluidly connecting the intake openings and exit openings.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Milk-based nutritional compositions containing lactoferrin and uses thereof

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Mead Johnson Nutrition Company patent solves the following problem:

Lactoferrin, an iron-binding glycoprotein, is one of the major multifunctional house agents in human milk. It has the capacity to bind to two molecules of iron in a consistent manner and facilitate the uptake of iron in the intestine. Moreover, lactoferrin has been shown that both bacteriostatic and bactericidal, and it helps to prevent intestinal infections in humans, especially in pediatric subjects.

Our analysis of this patent is as follows:

Mead Johnson Nutrition Company’s patent US 8968722 B2 deals with Milk-based nutritional compositions containing lactoferrin and uses thereof.
The present disclosure relates to milk-based nutritional composition comprising lactoferrin and / or a prebiotic component, which, when combined, lactoferrin and prebiotic component to show additive or synergistic beneficial effects on the health and development of a pediatric subjects. disclosure further relates to methods comprising the administration of the milk-based nutritional composition in pediatric subjects.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.